openPR Logo
Press release

U.S. Vital Signs Monitoring Devices Market to Reach USD 11 Billion by 2028, Growing at a CAGR of 7.6% - Arizton

U.S. Vital Signs Monitoring Devices Market to Reach USD 11

According to Arizton's latest research report, the U.S. vital signs monitoring devices market will grow at a CAGR of 7.6% from 2022 to 2028. Increasing demand for wireless patient monitoring at home, the rise of virtual clinical trials, advances in remote patient monitoring technology, and upcoming technologies in vital signs monitoring are trends in the market. Vendors are leveraging innovative technology platforms to develop vital signs monitoring devices with advanced features. Vendors strategically focus on the development and commercial launches of their standalone or integrated vital signs monitors for patients' vital signs. New product approvals/launches coupled with R&D activities assist vendors in expanding their presence, enhancing market growth, and sustaining their market position in the vital signs monitoring devices market.
The COVID-19 pandemic has accelerated the shift and made healthcare settings reduce costs and increase value-based treatments provided in the market. Vendors in vital sign monitoring and remote patient monitoring have a significant opportunity to handle the shift in the healthcare landscape in this scenario. Most patients are treated more for chronic diseases than other conditions, and a major portion of the healthcare expenditure in the US goes toward treating and monitoring chronic diseases; therefore, vital signs monitors, and remote patient monitoring devices will have a major impact on the future of the US healthcare market. Post-COVID-19 healthcare settings have invested hugely in virtual care, online consultations, and home healthcare. Zyter, a US-based startup, providing telehealth and IoT-enabled platforms, recently launched its home health and RPM solution. The solution tracks data from a blood pressure cuff, pulse oximeter, digital weight scale, or blood glucose monitor from the comfort of home. The US Military currently uses the system to track the condition of military personnel admitted in ICUs at various military bases worldwide from a central location in the US.

If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3710

RECENT VENDOR'S ACTIVITIES IN THE U.S. VITAL SIGNS MONITORING DEVICES MARKET
• In January 2022, ICU Medical acquired Smiths Medical. The addition of vital care products expanded the business range of ICU Medical with a robust reach.
• In December 2021, Baxter acquired Hillrom, a medical technology leader. Before that, in January 2021, Hillrom acquired Bardy Diagnostics, an innovator in digital health and a leading provider of ambulatory cardiac monitoring technologies.
• In February 2021, Koninklijke Philips completed the acquisition of BioTelemetry. The acquisition of BioTelemetry is a strong fit with Philips' cardiac care portfolio. The combination results in the business expansion of patient care management solutions for the hospital and homes.

Click Here to Download the Free Sample Report: https://www.arizton.com/request-sample/3710

KEY COMPANY PROFILES
• A&D Company
• Baxter
• CONTEC MEDICAL SYSTEMS
• GE Healthcare
• ICU Medical
• Koninklijke Philips
• Masimo
• Medtronic
• NIHON KOHDEN
• Nonin
• OMRON
• OSI Systems
• 100-Plus
• Advanced Instrumentations
• American Diagnostic
• Bittium
• Cardinal Health
• Compass Health Brands
• Drägerwerk AG & Co.
• EDAN Instruments
• FUKUDA DENSHI
• Halma
• Infinium Medical
• Mennen Medical
• Microlife
• NURECA
• Oxitone
• Qardio
• Rossmax International
• Solaris Medical Technology
• Sunset Healthcare Solutions
• Viatom Technology
• VitalConnect
• VivaLNK
• VYAIRE MEDICAL
MARKET SEGMENTATION
Product
• Standalone Vital Sign Monitoring Devices
o Heart Rate/Cardiac Monitors
o Pulse Oximeters
o Blood Pressure Monitors
o Body Temperature Monitors
• Integrated Vital Sign Monitoring Devices
Patient Group
• Geriatric Patient Group
• Adult Patient Group
• Pediatric Patient Group
Application
• Chronic Care
• Acute Care
End-user
• Hospitals
• Homecare Settings & Individuals
• Ambulatory Care Settings
• Others

Know more: https://www.arizton.com/market-reports/us-vital-signs-monitoring-devices-market

TABLE OF CONTENT
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY PATIENT GROUP
4.3.3 MARKET SEGMENTATION BY APPLICATION
4.3.4 MARKET SEGMENTATION BY END-USER
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 MARKET OVERVIEW
8 INTRODUCTION
8.1 OVERVIEW
8.1.1 COVID-19 IMPACT
8.1.2 REIMBURSEMENT SCENARIO FOR VITAL SIGNS MONITORS
8.1.3 WEARABLE TECHNOLOGY IN VITAL SIGNS MONITORING DEVICES
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASING DEMAND FOR WIRELESS PATIENT MONITORING AT HOME
9.2 RISE OF VIRTUAL CLINICAL TRIALS
9.3 ADVANCES IN REMOTE PATIENT MONITORING TECHNOLOGY
9.4 UPCOMING TECHNOLOGIES IN VITAL SIGNS MONITORING
10 MARKET GROWTH ENABLERS
10.1 INCREASING PREVALENCE OF CHRONIC DISORDERS AUGMENTING CONTINUOUS
MONITORING DEMAND
10.2 ENCHANCEMENTS IN VITAL SIGNS MONITORS
10.3 INCREASED PREFERENCE FOR INTEGRATED VITAL SIGNS MONITORS
10.4 INCREASING FOCUS ON DEVELOPING SOFTWARE & APPS FOR VITAL SIGNS
MONITORING BY MANUFACTURERS
11 MARKET RESTRAINTS
11.1 CYBERSECURITY & RELATED LIMITATIONS WITH VITAL SIGNS MONITORS
11.2 FALSE ALARMS & ALARM FATIGUE ASSOCIATED WITH VITAL SIGNS MONITORS
11.3 INTENSE COMPETITION COUPLED WITH PRICING PRESSURES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 PRODUCT SEGMENTATION INSIGHTS
12.2.2 PATIENT GROUP SEGMENTATION INSIGHTS
12.2.3 APPLICATION SEGMENTATION INSIGHTS
12.2.4 END-USER SEGMENTATION INSIGHTS
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 THREAT OF RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 STANDALONE VITAL SIGNS MONITORS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 HEART RATE/CARDIAC MONITORS
13.3.4 PULSE OXIMETERS: MARKET SIZE AND FORECAST
13.3.5 BLOOD PRESSURE MONITORS: MARKET SIZE AND FORECAST
13.3.6 BODY TEMPERATURE MONITORS
13.4 INTEGRATED VITAL SIGNS MONITORS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
14 PATIENT GROUP
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 GERIATRIC PATIENT GROUP
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 ADULT PATIENT GROUP
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 PEDIATRIC PATIENT GROUP
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
15 APPLICATION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 CHRONIC CARE
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.4 ACUTE CARE
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.2.1 KEY BUYING CRITERIA AND BUYING BEHAVIOR PATTERNS
16.3 HOSPITALS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.4 AMBULATORY CARE SETTINGS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 HOMECARE SETTINGS & INDIVIDUALS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 OTHERS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
17 COMPETITIVE LANDSCAPE
17.1 COMPETITION OVERVIEW
17.1.1 VENDORS RECENT ACTIVITIES: M&AS AND PRODUCT LAUNCHES
17.2 MARKET SHARE ANALYSIS
17.2.1 A&D COMPANY
17.2.2 BAXTER
17.2.3 CONTEC MEDICAL SYSTEMS
17.2.4 GE HEALTHCARE
17.2.5 ICU MEDICAL
17.2.6 KONINKLIJKE PHILIPS
17.2.7 MASIMO
17.2.8 MEDTRONIC
17.2.9 NIHON KOHDEN
17.2.10 NONIN
17.2.11 OMRON
17.2.12 OSI SYSTEMS
18 KEY COMPANY PROFILES
18.1 A&D COMPANY
18.1.1 BUSINESS OVERVIEW
18.1.2 PRODUCT OFFERINGS
18.1.3 KEY STRATEGIES
18.1.4 KEY STRENGTHS
18.1.5 KEY OPPORTUNITIES
18.2 BAXTER
18.2.1 BUSINESS OVERVIEW
18.2.2 PRODUCT OFFERINGS
18.2.3 KEY STRATEGIES
18.2.4 KEY STRENGTHS
18.2.5 KEY OPPORTUNITIES
18.3 CONTEC MEDICAL SYSTEMS
18.3.1 BUSINESS OVERVIEW
18.3.2 PRODUCT OFFERINGS
18.3.3 KEY STRATEGIES
18.3.4 KEY STRENGTHS
18.3.5 KEY OPPORTUNITIES
18.4 GE HEALTHCARE
18.4.1 BUSINESS OVERVIEW
18.4.2 PRODUCT OFFERINGS
18.4.3 KEY STRATEGIES
18.4.4 KEY STRENGTHS
18.4.5 KEY OPPORTUNITIES
18.5 ICU MEDICAL
18.5.1 BUSINESS OVERVIEW
18.5.2 PRODUCT OFFERINGS
18.5.3 KEY STRATEGIES
18.5.4 KEY STRENGTHS
18.5.5 KEY OPPORTUNITIES
18.6 KONINKLIJKE PHILIPS
18.6.1 BUSINESS OVERVIEW
18.6.2 PRODUCT OFFERINGS
18.6.3 KEY STRATEGIES
18.6.4 KEY STRENGTHS
18.6.5 KEY OPPORTUNITIES
18.7 MASIMO
18.7.1 BUSINESS OVERVIEW
18.7.2 PRODUCT OFFERINGS
18.7.3 KEY STRATEGIES
18.7.4 KEY STRENGTHS
18.7.5 KEY OPPORTUNITIES
18.8 MEDTRONIC
18.8.1 BUSINESS OVERVIEW
18.8.2 PRODUCT OFFERINGS
18.8.3 KEY STRATEGIES
18.8.4 KEY STRENGTHS
18.8.5 KEY OPPORTUNITIES
18.9 NIHON KOHDEN
18.9.1 BUSINESS OVERVIEW
18.9.2 PRODUCT OFFERINGS
18.9.3 KEY STRATEGIES
18.9.4 KEY STRENGTHS
18.9.5 KEY OPPORTUNITIES
18.10 NONIN
18.10.1 BUSINESS OVERVIEW
18.10.2 PRODUCT OFFERINGS
18.10.3 KEY STRATEGIES
18.10.4 KEY STRENGTHS
18.10.5 KEY OPPORTUNITIES
18.11 OMRON
18.11.1 BUSINESS OVERVIEW
18.11.2 PRODUCT OFFERINGS
18.11.3 KEY STRATEGIES
18.11.4 KEY STRENGTHS
18.11.5 KEY OPPORTUNITIES
18.12 OSI SYSTEMS
18.12.1 BUSINESS OVERVIEW
18.12.2 PRODUCT OFFERINGS
18.12.3 KEY STRATEGIES
18.12.4 KEY STRENGTHS
18.12.5 KEY OPPORTUNITIES
19 OTHER PROMINENT VENDORS
19.1 100-PLUS
19.2 ADVANCED INSTRUMENTATIONS
19.3 AMERICAN DIAGNOSTIC
19.4 BITTIUM
19.5 CARDINAL HEALTH
19.6 COMPASS HEALTH BRANDS
19.7 DRÄGERWERK AG & CO.
19.8 EDAN INSTRUMENTS
19.9 FUKUDA DENSHI
19.1 HALMA
19.11 INFINIUM MEDICAL
19.12 MENNEN MEDICAL
19.13 MICROLIFE
19.14 NURECA
19.15 OXITONE
19.16 QARDIO
19.17 ROSSMAX INTERNATIONAL
19.18 SOLARIS MEDICAL TECHNOLOGY
19.19 SUNSET HEALTHCARE SOLUTIONS
19.20 VIATOM TECHNOLOGY
19.21 VITALCONNECT
19.22 VIVALNK
19.23 VYAIRE MEDICAL
20 REPORT SUMMARY
20.1 KEY TAKEAWAYS
20.2 STRATEGIC RECOMMENDATIONS
21 QUANTITATIVE SUMMARY
21.1 MARKET BY PRODUCT
21.2 MARKET BY PATIENT GROUP
21.3 MARKET BY APPLICATION
21.4 MARKET BY END-USER
22 APPENDIX
22.1 ABBREVIATIONS

About Us:  
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. 
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. 

Call: +1-312-235-2040 
          +1 302 469 0707 
Mail: enquiry@arizton.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Vital Signs Monitoring Devices Market to Reach USD 11 Billion by 2028, Growing at a CAGR of 7.6% - Arizton here

News-ID: 2928386 • Views:

More Releases for KEY

Caprylyl Glycine Market Size, Share and Forecast By Key Players-Key Player I, Ke …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Caprylyl Glycine market is anticipated to grow at a compound annual growth rate (CAGR) of 16.41% between 2024 and 2031. The market is expected to grow to USD 11.09 Billion by 2024. The valuation is expected to reach USD 32.12 Billion by 2031. The Caprylyl Glycine market is experiencing significant growth, driven by its increasing demand in the
Polyurethane Prepolymer (PPU) Market Size, Share and Forecast By Key Players-Key …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Polyurethane Prepolymer (PPU) market is anticipated to grow at a compound annual growth rate (CAGR) of 11.68% between 2024 and 2031. The market is expected to grow to USD 8.1 Billion by 2024. The valuation is expected to reach USD 17.54 Billion by 2031. The Polyurethane Prepolymer (PPU) Market is set for significant growth, driven by increasing demand
Olivine Sand Market Size, Share and Forecast By Key Players-Key Player I, Key Pl …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Olivine Sand market is anticipated to grow at a compound annual growth rate (CAGR) of 16.07% between 2024 and 2031. The market is expected to grow to USD 39 Billion by 2024. The valuation is expected to reach USD 110.69 Billion by 2031. The olivine sand market is poised for significant growth due to its increasing use in
Phlorotannins Market Analysis By Top Keyplayers - Key Player I, Key Player II, K …
The "Phlorotannins Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Phlorotannins Market, 2024-2031 Verified Market Research's most recent report, "Phlorotannins Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry
Direct Drive Frameless Motor Market Size, Insights 2031 by Key Vendors- Key Play …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Direct Drive Frameless Motor Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a 𝐂𝐀𝐆𝐑 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏. The Direct Drive Frameless Motor Market presents significant opportunities for growth driven by advancements in technology and the increasing demand for high-performance, precision-driven applications across various industries.
Hydroxylamine Hcl Market Size, Share Projections 2031 by Key Manufacturer- Key P …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Hydroxylamine Hcl Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a 𝐂𝐀𝐆𝐑 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏. The Hydroxylamine HCl Market offers substantial opportunities for growth driven by its diverse applications across various industries. Hydroxylamine hydrochloride is widely used as a reducing agent in chemical synthesis,